Bandingkan Harga & Kinerja Logindo Samudramakmur Tbk. (LEAD) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Logindo Samudramakmur Tbk. dan Organon Pharma Indonesia Tbk.: Logindo Samudramakmur Tbk. diperdagangkan di Rp112 (kapitalisasi pasar 643,76 M, volume 24 jam 26,74 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Logindo Samudramakmur Tbk. jauh lebih besar — sekitar 6,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| LEAD | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 643,76 M | 104,4 M |
Volume | 26,74 jt | — |
Lot | 267,43 rb | — |
Perputaran | 2,9 M | — |
Harga Rata-rata | 108,62 | — |
Nilai Transaksi | 2,9 M | — |
Harga Ekuilibrium Indikatif | 112 | — |
Volume Ekuilibrium Indikatif | 7,92 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Logindo Samudramakmur Tbk.
PT Logindo Samudramakmur Tbk (the Company) is domiciled and was established in Jakarta, Indonesia based on Notarial Deed No. 55 of Nurul Hidajati Handoko, SH., Public Notary in Jakarta dated August 23, 1995. The company currently owns and operates a fleet of 58 offshore support with various types and functions. The company has a portfolio of customers ranging from mining oil and gas local to multinational.
Selengkapnya di halaman LEAD →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
